Treatment With Biologic Therapy in Psoriasis Is Associated With a Reduction in Coronary Artery Inflammation, Assessed by Perivascular Fat Attenuation Index

Treatment With Biologic Therapy in Psoriasis Is Associated With a Reduction in Coronary Artery Inflammation

American College of Cardiology Conference: At the American College of Cardiology Conference, an exciting abstract from Scientists at the US National Institute of Health (NIH) was presented showing a statistically-significant reduction in FAI™ associated with anti-inflammatory treatment for psoriasis. Psoriasis is commonly associated with increased risk of vascular inflammation and CV events. This landmark finding that highlights the dynamic nature of FAI™ means it is poised to become a standard measure of treatment response in CVD.

Read More…